21 Stocks Moving in Thursday's Pre-Market Session

Gainers

• Cardiff Oncology, Inc. CRDF rose 17.3% to $8.27 in pre-market trading after the company announced new data from its Phase 1b/2 trial in KRAS-mutated metastatic colorectal cancer showing "robust objective response rate and progression free survival."
• TSR, Inc. TSRI rose 15.7% to $12.82 in pre-market trading. The company, last month, said it swung to a quarterly loss.
• Gold Royalty Corp. GROY rose 15.1% to $4.74 in pre-market trading. Gold Royalty, Abitibi Royalties and Golden Valley recently announced plans to combine to create a leading growth and Americas-focused precious metals royalty company.
• ProQR Therapeutics N.V. PRQR rose 15% to $7.83 in pre-market trading after the company announced Axiomer RNA editing licensing and research collaboration with Lilly.
• Lululemon Athletica Inc. LULU shares rose 13.3% to $431.66 in pre-market trading after the company reported better-than-expected Q2 results and issued strong Q3 revenue guidance.
• Torrid Holdings Inc. CURV rose 12.7% to $20.81 in pre-market trading after the company reported better-than-expected Q2 results.
• VPC Impact Acquisition Holdings VIH shares rose 5.7% to $10.95 in pre-market trading after declining around 6% on Wednesday.
• Sonim Technologies, Inc. SONM rose 5% to $0.51 in pre-market trading. Sonim Technologies, last month, reported a Q2 loss of $0.10 per share.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Humanigen, Inc. HGEN shares fell 54.5% to $6.87 in pre-market trading after the company disclosed that the FDA has declined its request for emergency use authorization of lenzilumab in hospitalized COVID-19 patients.
• Helbiz, Inc. HLBZ shares fell 21.1% to $10.26 in pre-market trading after jumping 84% on Wednesday. Helbiz launched a fleet of 150 e-scooters in Durham, North Carolina, after securing a one-year permit.
• Couchbase, Inc. BASE shares fell 16.6% to $43.00 in pre-market trading after the company reported a wider loss for its second quarter.
• Certara, Inc. CERT shares fell 8.2% to $32.26 in pre-market trading after the company reported pricing of public offering of common stock.
• The Boston Beer Company, Inc. SAM fell 8.1% to $514.00 in pre-market trading after the company announced it withdrew 2021 financial guidance.
• GameStop Corp. GME fell 7.6% to $183.65 in pre-market trading after the company reported wider-than-expected Q2 loss.
• eFFECTOR Therapeutics, Inc. EFTR fell 7.6% to $25.12 in pre-market trading after surging around 112% on Wednesday.
• NetEase, Inc. NTES fell 7.1% to $84.30 in pre-market trading on renewed regulatory concerns in China.
• Mechel PAO MTL fell 7% to $4.12 in pre-market trading after tumbling over 11% on Wednesday. The company recently reported Q2 results, including a 43% quarter-over-quarter revenue growth.
• Forte Biosciences, Inc. FBRX fell 7% to $3.86 in pre-market trading. Forte Biosciences recently announced the clinical trial of FB-401 for the treatment of atopic dermatitis failed to meet statistical significance.
• HUYA Inc. HUYA shares fell 6.5% to $10.14 in pre-market trading. HUYA’s CFO Catherine Xiaozheng Liu resigned for personal reasons, effective September 8, 2021.
• Bilibili Inc. BILI fell 6.1% to $80.60 in pre-market trading amid regulatory concerns following reports Chinese regulators have summoned gaming companies as part of a continued crackdown in the sector.
• DouYu International Holdings Limited DOYU shares fell 5% to $3.80 in pre-market trading after dropping over 6% on Wednesday. The company’s board recently authorized a share buyback program of up to $100 million of its ordinary shares.